Press and Media

May 10, 2025

Hundreds Attend Neurogen Biomarking's Free Brain Health Day in Bronzeville Jahmir Young and Sen. Mattie Hunter Urge Taking Charge of Brain Health in Black Communities

More than 400 community members participated in Capturing Memories: A Free Brain Health Day held at Insight Hospital in Chicago's Bronzeville neighborhood.

May 1, 2025

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians

Neurogen's Brain Health Care Ecosystem Accelerates Access to Early Detection Technology for Alzheimer's dementia and Mild Cognitive Impairment

Feb. 19, 2025

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Neurogen Biomarking's Brain Health Care Ecosystem Gives Patients Easier Access to Clinically Validated Blood Biomarker Technology

Jan. 14, 2025

Neurogen Biomarking Announces Collaboration with Linus Health Bringing Easy Access to Cutting-Edge Technology to Support Early Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease.

Neurogen Biomarking, the world’s first ecosystem for memory loss with end-to-end patient support and Linus Health, a digital health company focused on transforming brain health for people worldwide, finalized an agreement to integrate Linus Health's scientifically-validated digital cognitive assessments into the Neurogen Biomarking ecosystem.

Jan. 10, 2025

Introducing Neurogen Biomarking

Neurogen Biomarking is the first comprehensive platform designed to enable early detection and care for Mild Cognitive Impairment (MCI) and dementia associated with Alzheimer’s disease (AD). Neurogen Biomarking’s driving force is to solve the issue of delayed detection and ultimately diagnosis by empowering patients in a scientifically and clinically controlled ecosystem while also guiding them every step of the way in their brain health journey.